Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of the medication.

Over the past six months, Eli Lilly has earned significant wins over its Denmark-based rival and is still at it. Recent clinical trial results Eli Lilly released suggest that it is building a lead in ...

Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...

Years before Novo Nordisk's obesity drug Wegovy became a U.S. blockbuster, then-CEO Lars Rebien Sorensen told a press ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

Blood and urine tests might be able to reveal how much of your diet is made up of industrially produced foods, a new study ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Ltd. is advancing its commitment to sustainable weight management among Thais through the launch of the 'From My Weight to My Heart' campaign, aimed at reducing the risk of cardiovascular diseases and ...

Novo Nordisk, the global pharmaceutical leader headquartered in Denmark, has launched a major initiative to combat Thailand's growing obesity crisis, where more than 40% of the population is now ...

Queen Latifah exclusively told Us Weekly about 'The Equalizer' coming to an end — and whether there is hope for a return ...